Two allyldimethylalkyl quaternary ammonium salt (AQAS) monomers, N,N-dimethylallylphenylpropylammonium bromide (AQAS1) and N,N-dimethylallylnonylammonium bromide (AQAS2), were synthesized and used to prepare modified polyacrylamide materials. Two new drag reducers were synthesized from acrylamide (AM), sodium acrylate (NaAA) and a cationic modified monomer (AQAS1 or AQAS2) via aqueous solution polymerization, and the copolymers were named P(AM/NaAA/AQAS1) and P(AM/NaAA/AQAS2), respectively. The structures of the drag reduction agents were confirmed by IR and 1H NMR spectroscopies. The molecular weight (Mw) of P(AM/NaAA/AQAS1) was 1.79 × 106 g/mol. When the copolymer concentration is 1000 mg/L and the flow rate is 45 L/min, in fresh water the highest drag reduction rate was 75.8%, in 10,000 mg/L NaCl solution the drag reduction rate decreased to 72.9%. The molecular weight of P(AM/NaAA/AQAS2) was 3.17 × 106 g/mol. When the copolymer concentration is 500 mg/L and the flow rate is 45 L/min, the drag reduction rate reached 75.2%, and in 10,000 mg/L NaCl solution the drag reduction rate was 73.3%, decreased by approximately 1.9%. The drag reduction rate for partially hydrolyzed polyacrylamide (HPAM) was also investigated, and the results showed that the drag reduction rates for 500 and 1000 mg/L HPAM solutions were merely 43.2% and 49.0% in brine, respectively. Compared with HPAM, both of the above copolymers presented better drag reduction capacities.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: